Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A McCullers

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Vaccine|May 1, 2016
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infectionHana Hakim, Kim J Allison, Lee-Ann Van de Velde, et al.
The American Journal of Pathology|April 25, 2012
A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in miceEike R Hrincius, Ann-Katrin Hennecke, Lisa Gensler, et al.
Plos Computational Biology|March 8, 2011
Effect of 1918 PB1-F2 expression on influenza A virus infection kineticsAmber M Smith, Frederick R Adler, Julie L McAuley, et al.
Plos Pathogens|April 5, 2013
Kinetics of coinfection with influenza A virus and Streptococcus pneumoniaeAmber M Smith, Frederick R Adler, Ruy M Ribeiro, et al.
Paediatric Anaesthesia|May 17, 2012
Risk of catheter-associated infection in young hematology/oncology patients receiving long-term peripheral nerve blocksDoralina L Anghelescu, Brittney L Harris, Lane G Faughnan, et al.
Cell Host & Microbe|November 17, 2007
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumoniaJulie L McAuley, Felicita Hornung, Kelli L Boyd, et al.
Vaccine|July 22, 2008
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infectionAbiodun D Ogunniyi, James C Paton, Alun C Kirby, et al.
Cell Reports|June 9, 2015
Acute Lung Injury Results from Innate Sensing of Viruses by an ER Stress PathwayEike R Hrincius, Swantje Liedmann, David Finkelstein, et al.
Journal of Virology|September 23, 2011
Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82Irina V Alymova, Amanda M Green, Nicholas van de Velde, et al.
Journal of Virology|June 8, 2012
Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogensJenni N Weeks-Gorospe, Heather R Hurtig, Amy R Iverson, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Vaccine|May 1, 2016
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infectionHana Hakim, Kim J Allison, Lee-Ann Van de Velde, et al.
The American Journal of Pathology|April 25, 2012
A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in miceEike R Hrincius, Ann-Katrin Hennecke, Lisa Gensler, et al.
Plos Computational Biology|March 8, 2011
Effect of 1918 PB1-F2 expression on influenza A virus infection kineticsAmber M Smith, Frederick R Adler, Julie L McAuley, et al.
Plos Pathogens|April 5, 2013
Kinetics of coinfection with influenza A virus and Streptococcus pneumoniaeAmber M Smith, Frederick R Adler, Ruy M Ribeiro, et al.
Paediatric Anaesthesia|May 17, 2012
Risk of catheter-associated infection in young hematology/oncology patients receiving long-term peripheral nerve blocksDoralina L Anghelescu, Brittney L Harris, Lane G Faughnan, et al.
Cell Host & Microbe|November 17, 2007
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumoniaJulie L McAuley, Felicita Hornung, Kelli L Boyd, et al.
Vaccine|July 22, 2008
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infectionAbiodun D Ogunniyi, James C Paton, Alun C Kirby, et al.
Cell Reports|June 9, 2015
Acute Lung Injury Results from Innate Sensing of Viruses by an ER Stress PathwayEike R Hrincius, Swantje Liedmann, David Finkelstein, et al.
Journal of Virology|September 23, 2011
Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82Irina V Alymova, Amanda M Green, Nicholas van de Velde, et al.
Journal of Virology|June 8, 2012
Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogensJenni N Weeks-Gorospe, Heather R Hurtig, Amy R Iverson, et al.
Pageof 14